美国 · SEC FORM 4
Werewolf Therapeutics, Inc.
HOWL · Nasdaq · CIK 0001785530 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
52 同一窗口内观察到的 Form 4 交易行
52 sales · 0 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-05-14 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. · $159.3K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
EVNIN LUKEDirector
▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼▼
Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M.TenPercentOwner
▼▼▼▼▼▼▼▼▼▼
● 买入▼ 卖出○ 其他
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-05-14 · Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M..
近期 Form 4 活动
0买入
163卖出
0其他 Form 4 交易行
53SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出52 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 2,511,400
- 上期报告
- 1,705,956
- 日均成交量
- 679,291
- 回补天数
- 3.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-05-14 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | 买入 (P) | Common Stock | 162,539 | USD 0.98 | USD 159,288 | SEC 申报 ↗ |
| 2025-05-13 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | 买入 (P) | Common Stock | 52,974 | USD 0.98 | USD 51,915 | SEC 申报 ↗ |
| 2025-05-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Shah Rajeev M. | 买入 (P) | Common Stock | 320,913 | USD 0.86 | USD 275,985 | SEC 申报 ↗ |
| 2023-01-06 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 1,853,000 | USD 2.21 | USD 4,095,130 | SEC 申报 ↗ |
| 2021-06-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 9,285 | USD 13.37 | USD 124,140 | SEC 申报 ↗ |
| 2021-06-15 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 7,958 | USD 12.95 | USD 103,056 | SEC 申报 ↗ |
| 2021-06-14 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 306,055 | USD 12.75 | USD 3,902,201 | SEC 申报 ↗ |
| 2021-05-04 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 买入 (P) | Common Stock | 1,715,000 | USD 16.00 | USD 27,440,000 | SEC 申报 ↗ |
| 2021-05-04 | GADICKE ANSBERT; MPM ONCOLOGY INNOVATIONS FUND LP; MPM Oncology Impact Management GP LLC; MPM Oncology Impact Management LP; MPM Oncology Innovations Fund GP LLC; Oncology Impact Fund (Cayman) Management L.P.; UBS Oncology Impact Fund L.P. | 买入 (P) | Common Stock | 245,000 | USD 16.00 | USD 3,920,000 | SEC 申报 ↗ |
| 2021-05-04 | Foley Todd; MPM Asset Management Investors BV2014 LLC; MPM BioVentures 2014 (B), L.P.; MPM BioVentures 2014 GP LLC; MPM BioVentures 2014 LLC; MPM BioVentures 2014, L.P. | 买入 (P) | Common Stock | 125,759 | USD 16.00 | USD 2,012,144 | SEC 申报 ↗ |
| 2021-05-04 | EVNIN LUKE | 买入 (P) | Common Stock | 150,799 | USD 16.00 | USD 2,412,784 | SEC 申报 ↗ |
| 2021-05-04 | Taiho Ventures LLC | 买入 (P) | Common Stock | 312,500 | USD 16.00 | USD 5,000,000 | SEC 申报 ↗ |
| 2021-05-04 | SPHERA FUNDS MANAGEMENT LTD.; Sphera Global Healthcare GP Ltd.; Sphera Global Healthcare Management LP | 买入 (P) | Common Stock | 475,000 | USD 16.00 | USD 7,600,000 | SEC 申报 ↗ |
| 2021-05-04 | Longwood Fund III GP, LLC; Longwood Fund III, L.P. | 买入 (P) | Common Stock | 250,000 | USD 16.00 | USD 4,000,000 | SEC 申报 ↗ |
| 2021-05-04 | Lazarus Alon | 买入 (P) | Common Stock | 400,000 | USD 16.00 | USD 6,400,000 | SEC 申报 ↗ |
Form 4 申报证据
163 transaction lines in the latest 365-day window; 216 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | EVNIN LUKE | 卖出 (S) | Common Stock | 107,429 | USD 0.31 | USD 33,303 | SEC 申报 ↗ |
| 2026-07-06 | EVNIN LUKE | 卖出 (S) | Common Stock | 35,770 | USD 0.32 | USD 11,446 | SEC 申报 ↗ |
| 2026-06-29 | EVNIN LUKE | 卖出 (S) | Common Stock | 157,084 | USD 0.30 | USD 47,125 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | EVNIN LUKE | 卖出 (S) | Common Stock | 107,429 | USD 0.31 | USD 33,303 | SEC 申报 ↗ |
| 2026-07-06 | EVNIN LUKE | 卖出 (S) | Common Stock | 35,770 | USD 0.32 | USD 11,446 | SEC 申报 ↗ |
| 2026-06-29 | EVNIN LUKE | 卖出 (S) | Common Stock | 157,084 | USD 0.30 | USD 47,125 | SEC 申报 ↗ |
| 2026-06-17 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 416,911 | USD 0.35 | USD 145,919 | SEC 申报 ↗ |
| 2026-06-16 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 149,625 | USD 0.37 | USD 55,361 | SEC 申报 ↗ |
| 2026-06-15 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 128,770 | USD 0.39 | USD 50,220 | SEC 申报 ↗ |
| 2026-06-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 170,441 | USD 0.40 | USD 68,176 | SEC 申报 ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 262,503 | USD 0.38 | USD 99,751 | SEC 申报 ↗ |
| 2026-06-10 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 45,923 | USD 0.37 | USD 16,992 | SEC 申报 ↗ |
| 2026-06-09 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 369,800 | USD 0.37 | USD 136,826 | SEC 申报 ↗ |
| 2026-06-09 | EVNIN LUKE | 卖出 (S) | Common Stock | 76,928 | USD 0.37 | USD 28,463 | SEC 申报 ↗ |
| 2026-06-08 | EVNIN LUKE | 卖出 (S) | Common Stock | 60,547 | USD 0.40 | USD 24,219 | SEC 申报 ↗ |
| 2026-06-05 | EVNIN LUKE | 卖出 (S) | Common Stock | 24,946 | USD 0.40 | USD 9,978 | SEC 申报 ↗ |
| 2026-06-04 | EVNIN LUKE | 卖出 (S) | Common Stock | 20,072 | USD 0.44 | USD 8,832 | SEC 申报 ↗ |
| 2026-06-03 | EVNIN LUKE | 卖出 (S) | Common Stock | 29,749 | USD 0.42 | USD 12,495 | SEC 申报 ↗ |
| 2026-06-02 | EVNIN LUKE | 卖出 (S) | Common Stock | 29,595 | USD 0.45 | USD 13,318 | SEC 申报 ↗ |
| 2026-06-01 | EVNIN LUKE | 卖出 (S) | Common Stock | 80,459 | USD 0.47 | USD 37,816 | SEC 申报 ↗ |
| 2026-05-29 | EVNIN LUKE | 卖出 (S) | Common Stock | 32,556 | USD 0.45 | USD 14,650 | SEC 申报 ↗ |
| 2026-05-28 | EVNIN LUKE | 卖出 (S) | Common Stock | 27,698 | USD 0.46 | USD 12,741 | SEC 申报 ↗ |
| 2026-05-27 | EVNIN LUKE | 卖出 (S) | Common Stock | 80,852 | USD 0.48 | USD 38,809 | SEC 申报 ↗ |
| 2026-05-26 | EVNIN LUKE | 卖出 (S) | Common Stock | 67,950 | USD 0.47 | USD 31,936 | SEC 申报 ↗ |
| 2026-05-22 | EVNIN LUKE | 卖出 (S) | Common Stock | 87,425 | USD 0.45 | USD 39,341 | SEC 申报 ↗ |
| 2026-05-21 | EVNIN LUKE | 卖出 (S) | Common Stock | 36,387 | USD 0.42 | USD 15,283 | SEC 申报 ↗ |
| 2026-05-20 | EVNIN LUKE | 卖出 (S) | Common Stock | 85,895 | USD 0.43 | USD 36,935 | SEC 申报 ↗ |
| 2026-05-19 | EVNIN LUKE | 卖出 (S) | Common Stock | 62,970 | USD 0.45 | USD 28,336 | SEC 申报 ↗ |
| 2026-05-18 | EVNIN LUKE | 卖出 (S) | Common Stock | 22,184 | USD 0.50 | USD 11,092 | SEC 申报 ↗ |
| 2026-05-13 | EVNIN LUKE | 卖出 (S) | Common Stock | 44,679 | USD 0.54 | USD 24,127 | SEC 申报 ↗ |
| 2026-05-12 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 101,151 | USD 0.64 | USD 64,737 | SEC 申报 ↗ |
| 2026-05-12 | EVNIN LUKE | 卖出 (S) | Common Stock | 67,885 | USD 0.64 | USD 43,446 | SEC 申报 ↗ |
| 2026-05-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; Shah Rajeev M. | 卖出 (S) | Common Stock | 87,490 | USD 0.67 | USD 58,618 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | HOWL |
| CIK | 0001785530 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 216 transaction lines from 2021-05-04 to 2026-07-07 19 P purchase lines · 168 S sale lines · 29 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.